(NASDAQ: TNDM) Tandem Diabetes Care's forecast annual revenue growth rate of 11.16% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.22%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.66%.
Tandem Diabetes Care's revenue in 2024 is $796,002,000.On average, 7 Wall Street analysts forecast TNDM's revenue for 2024 to be $58,235,283,769, with the lowest TNDM revenue forecast at $58,080,459,280, and the highest TNDM revenue forecast at $58,394,690,800. On average, 7 Wall Street analysts forecast TNDM's revenue for 2025 to be $64,888,219,696, with the lowest TNDM revenue forecast at $62,905,222,410, and the highest TNDM revenue forecast at $67,657,974,150.
In 2026, TNDM is forecast to generate $71,590,908,947 in revenue, with the lowest revenue forecast at $68,371,541,560 and the highest revenue forecast at $74,256,836,070.